Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dihydroevocarpine (1-methyl-2-tridecylquinolin-4-one) induces AML cytotoxicity, apoptosis and G0/G1 blockade, and inhibits tumor growth by inhibiting mTORC1/2 activity and the mTOR pathway in an acute myeloid leukemia (AML) xenograft model.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $54 | In Stock | |
5 mg | $129 | In Stock | |
10 mg | $198 | In Stock | |
25 mg | $320 | In Stock | |
1 mL x 10 mM (in DMSO) | $142 | In Stock |
Description | Dihydroevocarpine (1-methyl-2-tridecylquinolin-4-one) induces AML cytotoxicity, apoptosis and G0/G1 blockade, and inhibits tumor growth by inhibiting mTORC1/2 activity and the mTOR pathway in an acute myeloid leukemia (AML) xenograft model. |
Targets&IC50 | CCRF-CEM cells:14.08 μM, CEM/ADR5000 cells:33.14 μM |
In vitro | Dihydroevocarpine exhibits moderate in vitro cytotoxicity against CCRF-CEM and CEM/ADR5000 leukemia cell lines, with IC₅₀ values of 14.08 μM and 33.14 μM, respectively. [1] |
In vivo | BALB/C nude mice bearing subcutaneous HL-60 leukemia cells were treated with intraperitoneal injections of Dihydroevocarpine (10 mg/kg/day) for 20 days, resulting in a significant antitumor effect.[2] |
Alias | 1-methyl-2-tridecylquinolin-4-one |
Molecular Weight | 341.53 |
Formula | C23H35NO |
Cas No. | 15266-35-0 |
Smiles | O=C1C=C(N(C=2C=CC=CC12)C)CCCCCCCCCCCCC |
Relative Density. | 0.964 g/cm3 (Predicted) |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 12 mg/mL (35.14 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.